XML 39 R29.htm IDEA: XBRL DOCUMENT
v3.24.3

Basis of presentation (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2024
Accounting Policies [Abstract] |
Schedule Of Impact Of Restatement On Certain Line Items And Balance Sheet | The tables below present the impact of the revision on the line items within the Company’s consolidated financial statements for the relevant periods:
|  | Three months ended |  |  | Nine months ended |
|  | September 30, 2023 |  |  | September 30, 2023 |
|  | U.S $ in millions (except per share amounts) |
|  | (Unaudited) |
|  | As previously reported |  |  | Adjustment |  |  | As revised |  |  | As previously reported |  |  | Adjustment |  |  | As revised |
Other asset impairments, restructuring and other items |  | $ | 46 |  |  |  | 11 |  |  |  | 57 |  |  | $ | 241 |  |  |  | 34 |  |  |  | 276 |
Operating income (loss) |  |  | 355 |  |  |  | (11 | ) |  |  | 344 |  |  |  | (289 | ) |  |  | (34 | ) |  |  | (323 | )
Income (loss) before income taxes |  |  | 75 |  |  |  | (11 | ) |  |  | 64 |  |  |  | (1,097 | ) |  |  | (34 | ) |  |  | (1,131 | )
Income taxes (benefit) |  |  | (12 | ) |  |  | § |  |  |  | (12 | ) |  |  | (48 | ) |  |  | § |  |  |  | (48 | )
Net income (loss) |  |  | 88 |  |  |  | (11 | ) |  |  | 77 |  |  |  | (1,048 | ) |  |  | (34 | ) |  |  | (1,082 | )
Net income (loss) attributable to Teva |  |  | 80 |  |  |  | (11 | ) |  |  | 69 |  |  |  | (988 | ) |  |  | (34 | ) |  |  | (1,022 | )
Earnings (loss) per share attributable to ordinary shareholders: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic and diluted loss per share |  | $ | 0.07 |  |  |  | (0.01 | ) |  |  | 0.06 |  |  | $ | (0.88 | ) |  |  | (0.04 | ) |  |  | (0.91 | )
§ | Represents an amount less than $0.5 million.
|  | September 30, 2023 |
|  | As previously reported |  |  | Adjustment |  |  | As revised |
|  | (Unaudited) |
Deferred income taxes |  | $ | 1,748 |  |  |  | 7 |  |  |  | 1,755 |
Total assets |  |  | 42,088 |  |  |  | 7 |  |  |  | 42,095 |
Other taxes and long-term liabilities |  |  | 3,818 |  |  |  | 132 |  |  |  | 3,950 |
Total long-term liabilities |  |  | 23,182 |  |  |  | 132 |  |  |  | 23,314 |
Total liabilities |  |  | 34,576 |  |  |  | 132 |  |  |  | 34,708 |
Teva shareholders’ equity: |  |  |  |  |  |  |  |  |  |  |  |
Accumulated deficit |  |  | (13,870 | ) |  |  | (125 | ) |  |  | (13,995 | )
Total equity |  |  | 7,512 |  |  |  | (125 | ) |  |  | 7,387 |
Total liabilities and equity |  | $ | 42,088 |  |  |  | 7 |  |  |  | 42,095 |

X
- References No definition available. + Details
Name: | us-gaap_AccountingPoliciesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 8 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 9 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9 + Details
Name: | us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration